EP2057156
2-Metýlmorfólínpýrídó-, pýrasó- og pýrímíðó-pýrímídínafleiður sem hemlar á MTOR
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
21.8.2007EP published:
1.2.2017EP application number:
07789277.6
EP translation filed:
25.4.2017Grant published:
15.5.2017EPO information:
European Patent Register
Max expiry date:
20.8.2027Expiry date:
20.8.2021
Title:
2-METHYLMORPHOLINE PYRIDO-,PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS
Timeline
Today
21.8.2007EP application
1.2.2017EP Publication
25.4.2017Translation submitted
15.5.2017Registration published
20.8.2021Expires
Owner
Name:
KuDOS Pharmaceuticals LimitedAddress:
1 Francis Crick Avenue, Cambridge Biomedical CampusCambridgeCB2 0AA, GB
Inventor
Name:
DUGGAN, Heather Mary EllenAddress:
Cambridge CB4 0PE, GB
Name:
LEROUX, Frederic Georges MarieAddress:
Cambridge CB4 0PE, GB
Name:
MALAGU, KarineAddress:
Cambridge CB4 0PE, GB
Name:
MARTIN, Niall, Morrisson, BarrAddress:
CambridgeCambridgeshire CB4 0PE, GB
Name:
MENEAR, Keith, AllanAddress:
Cambridge CB4 0PE, GB
Name:
SMITH, Graeme, Cameron, MurrayAddress:
CambridgeCambridgeshire CB4 0PE, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
823311 PDate:
23.8.2006Country:
US
Number:
938776 PDate:
18.5.2007Country:
US
Classification
Categories:
C07D 471/04, A61K 31/519
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 7.7.2017
Expires: 20.8.2018
Payer: Árnason Faktor
Number: 12
Paid: 6.7.2018
Expires: 20.8.2019
Payer: Árnason Faktor
Number: 13
Paid: 9.7.2019
Expires: 20.8.2020
Payer: Árnason Faktor
Number: 14
Paid: 8.7.2020
Expires: 20.8.2021
Payer: Árnason Faktor ehf.